Guo Longcheng, Wambui Joseph, Wang Chenhui, Muchaamba Francis, Fernandez-Cantos Maria Victoria, Broos Jaap, Tasara Taurai, Kuipers Oscar P, Stephan Roger
Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen , Groningen, the Netherlands.
Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich , Zurich, Switzerland.
Microbiol Spectr. 2023 Sep 27;11(5):e0531922. doi: 10.1128/spectrum.05319-22.
Nisin is a widely used lantibiotic owing to its potent antimicrobial activity and its food-grade status. Its mode of action includes cell wall synthesis inhibition and pore formation, which are attributed to the lipid II binding and pore-forming domains, respectively. We discovered cesin, a short natural variant of nisin, produced by the psychrophilic anaerobe . Unlike other natural nisin variants, cesin lacks the two terminal macrocycles constituting the pore-forming domain. The current study aimed at heterologous expression and characterization of the antimicrobial activity and physicochemical properties of cesin. Following the successful heterologous expression of cesin in , the lantibiotic demonstrated a broad and potent antimicrobial profile comparable to that of nisin. Determination of its mode of action using lipid II and lipoteichoic acid binding assays linked the potent antimicrobial activity to lipid II binding and electrostatic interactions with teichoic acids. Fluorescence microscopy showed that cesin lacks pore-forming ability in its natural form. Stability tests have shown the lantibiotic is highly stable at different pH values and temperature conditions, but that it can be degraded by trypsin. However, a bioengineered analog, cesin R15G, overcame the trypsin degradation, while keeping full antimicrobial activity. This study shows that cesin is a novel (small) nisin variant that efficiently kills target bacteria by inhibiting cell wall synthesis without pore formation. IMPORTANCE The current increase in antibiotic-resistant pathogens necessitates the discovery and application of novel antimicrobials. In this regard, we recently discovered cesin, which is a short natural variant of nisin produced by the psychrophilic . However, its suitability as an antimicrobial compound was in doubt due to its structural resemblance to nisin(1-22), a bioengineered short variant of nisin with low antimicrobial activity. Here, we show by heterologous expression, purification, and characterization that the potency of cesin is not only much higher than that of nisin(1-22), but that it is even comparable to the full-length nisin, despite lacking two C-terminal rings that are essential for nisin's activity. We show that cesin is a suitable scaffold for bioengineering to improve its applicability, such as resistance to trypsin. This study demonstrates the suitability of cesin for future application in food and/or for health as a potent and stable antimicrobial compound.
乳链菌肽是一种广泛使用的羊毛硫抗生素,因其强大的抗菌活性和食品级地位。其作用方式包括抑制细胞壁合成和形成孔道,分别归因于脂质II结合域和孔道形成域。我们发现了cesin,它是嗜冷厌氧菌产生的一种短小的乳链菌肽天然变体。与其他天然乳链菌肽变体不同,cesin缺乏构成孔道形成域的两个末端大环。当前的研究旨在对cesin进行异源表达,并表征其抗菌活性和理化性质。在cesin在[具体宿主]中成功实现异源表达后,这种羊毛硫抗生素展现出了与乳链菌肽相当的广泛且强大的抗菌谱。通过脂质II和脂磷壁酸结合试验确定其作用方式,将其强大的抗菌活性与脂质II结合以及与磷壁酸的静电相互作用联系起来。荧光显微镜显示,cesin天然形式缺乏形成孔道的能力。稳定性测试表明,这种羊毛硫抗生素在不同pH值和温度条件下高度稳定,但可被胰蛋白酶降解。然而,一种生物工程类似物cesin R15G克服了胰蛋白酶降解问题,同时保持了完全的抗菌活性。这项研究表明,cesin是一种新型(短小)乳链菌肽变体,通过抑制细胞壁合成而不形成孔道来有效杀死靶细菌。重要性:当前抗生素耐药病原体的增加使得发现和应用新型抗菌剂成为必要。在这方面,我们最近发现了cesin,它是嗜冷菌产生的一种短小的乳链菌肽天然变体。然而,由于其结构与乳链菌肽(1 - 22)相似,后者是一种生物工程改造的低抗菌活性的乳链菌肽短变体,其作为抗菌化合物的适用性受到质疑。在此,我们通过异源表达纯化和表征表明,cesin的效力不仅远高于乳链菌肽(1 - 22),而且尽管缺乏对乳链菌肽活性至关重要的两个C末端环,但其效力甚至与全长乳链菌肽相当。我们表明,cesin是生物工程改造以提高其适用性(如对胰蛋白酶的抗性)的合适支架。这项研究证明了cesin作为一种强大且稳定的抗菌化合物在未来食品和/或健康领域应用的适用性。